GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: Rationale for its use

Reproductive BioMedicine Online

Volumn 19, Issue 2, 2009, Pages 156-161

  Martinez Salazar, J ^a   Cerrillo, M ^a   Quea, G ^a   Pacheco, A ^a   Garcia Velasco, J A ^a,b  

^a IVI Madrid   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

GnRH antagonist; Intrauterine insemination; Ovarian stimulation; Premature luteinization

Indexed keywords

GANIRELIX; LUTEINIZING HORMONE; PROGEFFIK; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVENING DOSAGE; FEMALE; FEMALE INFERTILITY; HORMONAL REGULATION; HUMAN; INCIDENCE; INTRAUTERINE INSEMINATION; LUTEINIZATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL;

EID: 69249099373     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60066-1     Document Type: Article

References (36)

1. Allegra A, Marino A, Coffaro F et al. 2007 GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial. Human Reproduction 22, 101-108.
2. Antoine JM 2004 GnRH antagonists in insemination: can we avoid weekends? Journal de Gynecologic Obstetrique et Biologie de la Reproduction 33, 3S50-52.
3. Barlow D 1998 GnRH agonist and in vitro fertilization. Journal of Reproductive Medicine 43, 245-251.
4. Bosch E, Valencia I, Escudero E et al. 2003 Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertility and Sterility 80, 1444-1449.
5. Cantineau A, Cohlen B, Heineman M 2007 Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Systematic Reviews 2, CD 005356.
6. Checa MA, Prat M, Robles A et al. 2006 Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertility and Sterility 85, 573-577.
7. Cohen J 1998 How to avoid multiple pregnancies in assisted reproduction. Human Reproduction 13 (Suppl. 3), 197-214; discussion 215-218.
8. Couzinet B, Schaison G 1993 The control of gonadotrophin secretion by ovarian steroids. Human Reproduction 8, 97-101.
9. Crosignani PG, Somigliana E 2007 Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Human Reproduction 22, 500-505.
10. Cunha-Filho J, Kadoch J, Righini C et al. 2003 Premature LH and progesterone rise in intrauterine insemination cycles: analysis of related factors. Reproductive BioMedicine Online 7, 194-199.
11. Diaz I, Guillen A, Pacheco A et al. 2008 Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonist vs human chorionic gonadotropin in women undergoing intrauterine insemination. Journal of Reproductive Medicine 53, 33-39.
12. Dodson WC, Haney AF 1991 Controlled ovarian hyperstimulation and intrauterine insemination for treatment of infertility. Fertility and Sterility 55, 457-467.
13. Dumesic DA 1994 Periovulatory serum progesterone levels as a predictor of pregnancy outcome during ovarian hyperstimulation for assisted reproductive technology. Fertility and Sterility 62, 911-912.
14. Edelstein MC, Seltman HJ, Cox BJ et al. 1990 Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertility and Sterility 54, 853-857.
15. Fanchin R, de Ziegler D, Taieb J et al. 1993 Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertility and Sterility 59, 1090-1094.
16. Filicori M, Cognini G, Gamberini E et al. 2005 Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertility and Sterility, 84, 394-401.
17. Gomez-Palomares JL, Acevedo-Martin B, Chavez M et al. 2007 Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles. Fertility and Sterility 89, 620-624.
18. Gomez-Palomares JL, Julia B, Acevedo-Martin B et al. 2005 Timing ovulation for intrauterine insemination with a GnRH antagonist. Human Reproduction 20, 368-372.
19. Goverde AJ, McDonnell J, Vermeiden JP et al. 2000 Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. Lancet 355, 13-18.
20. Guzick DS, Sullivan MW, Adamson GD et al. 1998 Efficacy of treatment for unexplained infertility. Fertility and Sterility 70, 207-213.
21. Hannoun A, Abu-Musa A, Kaspar H et al. 1998 Intrauterine insemination IUI: the effect of ovarian stimulation and infertility diagnosis on pregnancy outcome. Clinical and Experimental Obstetrics and Gynecology 25, 144-146.
22. Isaza V, Requena A, Garcia-Velasco JA et al. 2003 Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study. Journal of Reproductive Medicine 48, 112-118.
23. Kosmas IP, Tatsioni A, Kolibianakis EM et al. 2007 Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertility and Sterility 90, 367-372.
24. Lambalk CB, Leader A, Olivennes F et al. 2006 Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Human Reproduction 21, 632-639.
25. Lejeune B, Degueldre M, Camus M et al. 1986 In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Fertility and Sterility 45, 377-383.
26. Manzi DL, Dumez S, Scott LB et al. 1995 Selective use of leuprolide acetate in women undergoing superovulation with intrauterine insemination results in significant improvement in pregnancy outcome. Fertility and Sterility 63, 866-873.
27. Matorras R, Ramon O, Exposito A et al. 2006 Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. Journal of Assisted Reproduction and Genetics 23, 51-54.
28. Ragni G, Caliari I, Nicolosi AE et al. 2006 Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and Sterility 85, 619-624.
29. Ragni G, Alagna F, Brigante C et ai. 2004 GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages. Human Reproduction 19, 54-58.
30. Shapiro D, Mitchell-Leef D 2003 GnRH antagonist in in vitro fertilization: where we are now. Minerva Ginecologica 55, 373-388.
31. Silverberg KM, Burns WN, Olive DL et al. 1991 Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. Journal of Clinical Endocrinology and Metabolism 73, 797-803.
32. Ubaldi F, Albano C, Peukert M et al. 1996 Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Human Reproduction 11, 1405-1407.
33. Van Santbrinck E, Eijkemans M, Macklon N, Fauser B 2002 FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. European Journal of Endocrinology 147, 223-226.
34. Williams RS, Hillard JB, De Vane G et al. 2004 A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. American Journal of Obstetrics and Gynecology 191, 648-651; discussion 651-1643
35. Younis JS, Haddad S, Matilsky M et al. 1998 Premature luteinization: could it be an early manifestation of low ovarian reserve? Fertility and Sterility 69, 461-465.
36. Zikopoulos K, Kaponis A, Adonakis G et al. 2005 A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin- releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia. Fertility and Sterility 83, 1354-1362.